4.7 Review

Recent advancements in the molecular genetics of left ventricular noncompaction cardiomyopathy

Journal

CLINICA CHIMICA ACTA
Volume 465, Issue -, Pages 40-44

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.cca.2016.12.013

Keywords

Left ventricular noncompaction; Genetics; Noncompaction cardiomyopathy; Gene mutations

Funding

  1. National Science Foundation [81600305]
  2. Capital Medical Development and Scientific Research Foundation [2014-4-4035]
  3. Special Research Fund for the Doctoral Program of Higher Education [20131106120009]
  4. Youth Scientific Research Fund of PUMC [2014-XHQNO2-G]

Ask authors/readers for more resources

Left ventricular noncompaction cardiomyopathy (LVNC) is a myocardial disorder characterized by prominent and excessive trabeculations with deep recesses in the ventricular wall. Clinical manifestations of LVNC are highly variable, ranging from no symptoms to arrhythmias, heart failure, thromboembolism, or even sudden cardiac death. It is a heterogenetic disease which can be presented as an autosomal, X-linked or mitochondrial disorder. A series of candidate mutations have been identified in LVNC patients or murine models. It is generally believed that these gene mutations may share a final common pathway in the pathogenesis of LVNC, but the underlying molecular mechanisms are unknown. In this review, we discuss the gene mutations identified in LVNC patients and summarize recent advancements in the molecular genetic analysis of LVNC (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available